Skip to main content
Login | Suomeksi | På svenska | In English

Browsing by Subject "solunulkoiset vesikkelit"

Sort by: Order: Results:

  • Puutio, Johanna (2020)
    Extracellular vesicles (EVs) are phospholipid bilayer-enclosed nanoparticles that are secreted by eukaryotic and prokaryotic cells. EVs carry macromolecules and signalling molecules to adjacent cells and play an important role in intercellular communication under both pathologic and homeostatic conditions. Therefore, they have become of significant interest for their therapeutic, diagnostic and prognostic potential. EVs are small and highly heterogeneous in size, shape, cargo and membrane composition, posing several challenges for establishing analytical and clinical guidelines. Therefore, EV research requires standardized and robust methods for their separation and characterization. In this study physical and immunochemical methods were employed to characterize human platelet-derived EVs (pEVs) generated from platelets activated with different external biochemical stimuli. The platelet-activating effect of the pro-inflammatory S100A8/A9 protein complex and a combination of thrombin and collagen were studied with nano flow cytometry. The size distribution of pEVs was studied with nanoparticle tracking analysis (NTA) and asymmetrical flow field-flow fractionation (AF4), which represents a newly emerging method on the EV field. Finally, fluorescent labelling and co-localization analysis were employed to characterize membrane marker composition of pEVs and assess its usefulness as an analytic tool for EV research. We succeeded in providing new hints towards meaningful discoveries in platelet biology by characterizing the way platelets respond to inflammatory and hemostatic signals by shedding pEVs. When platelet activation markers are characterized with flow cytometry, the S100A8/A9 protein appeared to cause a shift in membrane activation markers when compared to the thrombin- collagen mix and the baseline control. Increased TLT-1 translocation and decreased integrin αIIbβ3 expression on pEV surfaces suggests that S100A8/A9 induced pEV secretion through differently packed platelet α-granules, rather than from the plasma membrane. An increase in TLT-1 expression compared to decreased P-selectin and αIIbβ3 suggests that S100A8/A9 stimulation shifts platelet phenotype towards secretion rather than aggregation. A protocol for small pEV separation with AF4-MALS was set up. With this method, subtle differences between small pEV populations were seen that were not distinguishable with NTA or flow cytometry. When investigated with AF4-MALS, S100A8/A9 induced pEVs appeared larger than those produced with thrombin- collagen activation. The mean particle sizes of the pEV populations obtained from activated platelets were generally also larger than those produced without an activator. We tested novel methods to detect subtle differences in small EV population sizes that are easily missed with conventional methods due to their technical limitations. A well-optimised AF4 protocol can detect different pEV subpopulations and is a promising tool for EV. In the future, when AF4 is combined with a MALS detector and a fraction collector, nanoimaging of fluorescently labelled EVs could be combined with it as a downstream application to obtain information on their versatile biological functions.
  • Niemeläinen, Elina (2020)
    Extracellular vesicles (EVs) are lipid bilayer-enclosed nano-sized particles that are found in all body fluids. EVs are part of normal cell functions and they can carry for example proteins, RNA and lipids between cells. This makes them potential candidates as drug delivery vehicles. When nanoparticles are introduced to blood plasma, a plasma protein structure is formed on their surface, called the protein corona. The formation of a protein corona is a dynamic process, and the proteins are binding to the corona depending on their affinity to the nanoparticle surface. When administrating nanoparticles to cells, protein corona has a big impact on the half-life and cellular uptake of the particles. The aim of this work was to study the plasma protein corona of PC-3 derived EVs, and to investigate methods for protein corona isolation. First, EVs and lipoprotein particles were removed from fresh frozen plasma by membrane filtration. Using this filtrated plasma, we then tested plasma-EV incubation and removing of free plasma proteins by simple ultrafiltration. Removing of free plasma proteins was also examined by size-exclusion chromatography (SEC). The resulting EV-protein corona complex was visualized with SDS-PAGE. EVs were characterized with nanoparticle tracking analysis and western blotting. Of these two methods used, SEC appeared to be more convenient and efficient way to remove the free plasma proteins from the EV-protein corona complex. The method still requires further development and testing in order to perform optimally.